Drug intelligence / Profile preview

Sunscreen C

Development stage: Preclinical
Lead developer: Johnson & Johnson Consumer Inc. (J&JCI)
Modality: Small Molecules
Administration: Topical

Overview

Sunscreen C is a facial sunscreen developed by Johnson & Johnson Consumer Inc. It is being evaluated in a single-center, comparative, randomized clinical study to assess its skin acceptability and efficacy in improving skin barrier function in adult participants with sensitive skin. The study specifically investigates two formulations, Sunscreen C Color 2.0 SPF 70 and Sunscreen C Color 3.0 SPF 70, applied topically. The evaluations include transepidermal water loss and sensory perception questionnaires to assess discomfort and tolerability.

Other names: Sunscreen C Color 2.0 SPF 70Sunscreen C Color 3.0 SPF 70

Beyond the preview

Go deeper on Sunscreen C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunscreen C.

Explore the full profile